Henry Schein Inc
NASDAQ:HSIC

Watchlist Manager
Henry Schein Inc Logo
Henry Schein Inc
NASDAQ:HSIC
Watchlist
Price: 73.62 USD 0.38% Market Closed
Market Cap: 8.7B USD

Henry Schein Inc
Stock-Based Compensation

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Henry Schein Inc
Stock-Based Compensation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Henry Schein Inc
NASDAQ:HSIC
Stock-Based Compensation
$38m
CAGR 3-Years
-16%
CAGR 5-Years
49%
CAGR 10-Years
-2%
Cardinal Health Inc
NYSE:CAH
Stock-Based Compensation
$307m
CAGR 3-Years
57%
CAGR 5-Years
26%
CAGR 10-Years
10%
Adapthealth Corp
NASDAQ:AHCO
Stock-Based Compensation
$21m
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Patterson Companies Inc
NASDAQ:PDCO
Stock-Based Compensation
$19.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mckesson Corp
NYSE:MCK
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cencora Inc
NYSE:COR
Stock-Based Compensation
$148m
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
9%
No Stocks Found

Henry Schein Inc
Glance View

In the evolving landscape of healthcare distribution, Henry Schein Inc. has carved out a robust niche, establishing itself as a pivotal player in delivering essential products and services. Founded in 1932, the company initially responded to the growing need for medical supplies with a simple commitment to customer service and innovation. Today, the company profiles as the world’s largest provider of healthcare products and services to office-based dental and medical practitioners, alongside its veterinary arm. It services a global footprint, channeling its efforts into dental, medical, and animal health sectors. The company's sprawling network deploys a vast array of products—from consumables to equipment—to a multitude of healthcare professionals, accentuating its integral role in the clinical toolkit. Henry Schein's revenue engine thrives on a meticulously crafted business model that combines the breadth of a comprehensive catalog with targeted value-added services. Its diverse product offerings span dental implants, vaccines, pharmaceuticals, and surgical supplies, delivered through direct sales and sophisticated logistical frameworks. Moreover, Henry Schein supplements its product lines with a suite of services, including practice management solutions and e-commerce platforms, that streamline operations for practitioners and enhance client loyalty. Strategic partnerships and acquisitions show the company's commitment to innovation, driving efficiencies and expanding its reach. This continuous adaptation keeps Henry Schein at the forefront of healthcare trends, ensuring steady streams of income flowing from both longstanding relationships and new market opportunities.

HSIC Intrinsic Value
106.16 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Henry Schein Inc's Stock-Based Compensation?
Stock-Based Compensation
38m USD

Based on the financial report for Sep 27, 2025, Henry Schein Inc's Stock-Based Compensation amounts to 38m USD.

What is Henry Schein Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
-2%

Over the last year, the Stock-Based Compensation growth was 23%. The average annual Stock-Based Compensation growth rates for Henry Schein Inc have been -16% over the past three years , 49% over the past five years , and -2% over the past ten years .

Back to Top